Exagen Inc. Achieves Key Milestone with 1,000,000th Patient Tested by AVISE® CTD
The milestone demonstrates AVISE CTD’s value and adoption within the rheumatologic community, clearly demonstrating superior laboratory testing for improved patient...
Medicare
BrainsWay Reports Positive Independent Pilot Data on Accelerated Deep TMS Treatment of Alcohol Use Disorder
BURLINGTON, Mass. and JERUSALEM, Dec. 12, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”),...
InnovAge Celebrates 35 Years of Transforming Senior Care
Has helped over 24,400 Seniors Age Safely at Home Since Its InceptionDENVER, Dec. 12, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding...
SeaStar Medical Projects Multibillion-Dollar Market Potential for its Selective Cytopheretic Device in Initial Target Indications
U.S. total addressable market for five initial indications is $25 to $33 billion REMINDER: Business Update Conference Call begins at...
New ALS Association-Led Research Finds Specialists Diagnose ALS Twice as Fast as General Neurologists
Groundbreaking thinkALS™ Tool Empowers Providers to Identify and Refer Patients Quicker ARLINGTON, Va., Dec. 10, 2024 /PRNewswire/ -- It can take...
Echo IQ Signs Integration Agreement With Flagship US Hospital
Integration agreement secured with Beth Israel Deaconess Medical Center, Boston USA Integration follows successful trial of EchoSolv-AS by Beth Israel...
MSSP ACOs using Milliman MedInsight achieved over $549.3M of earned savings in 2023 under CMS Medicare Shared Savings Program
Milliman MedInsight MSSP ACO clients see higher success rate than nationwide ACOs SEATTLE, Dec. 10, 2024 /PRNewswire/ -- Milliman MedInsight, a...
Bask Health: Pioneering Telehealth and Transforming Access to GLP-1 Medications in a Booming Industry
NEW YORK, Dec. 10, 2024 /PRNewswire/ -- The demand for GLP-1 medications is skyrocketing, with studies predicting the market will...
Senior Market Sales® (SMS) Acquires Centurion Senior Services
Successful Medicare Insurance Agency Expands SMS' Eastern U.S. Distribution OMAHA, Neb., Dec. 10, 2024 /PRNewswire/ -- In a quest to...
NeurAxis Inc. Announces FDA 510(k) Clearance of RED for Testing and Evaluation of Patients with Chronic Constipation
RED has been designed to duplicate test performance of traditional balloon expulsion test (BET) and manual sensation testing devices without...
Compliancy Group Releases Exclusion List Monitoring and Verification Tool
NEW YORK, Dec. 10, 2024 /PRNewswire/ -- Compliancy Group releases exclusion list monitoring and verification tool that automates employee and...
ASBM Responds to PCMA: Put Patients First, Not PBM Profits
ARLINGTON, VA / ACCESSWIRE / December 9, 2024 / As the Senate moves this week to advance passage of the...
Alliant Health Solutions Announces Promotion of Dr. Natasha Avery to Chief Operating Officer
ATLANTA, GA / ACCESSWIRE / December 9, 2024 / Alliant Health Solutions is pleased to announce the promotion of Dr....
Multi-Million Drug Therapy Innovations Bring Challenges to Healthcare
Pharmacy Forecast outlines pharmacy leaders' roles in innovation NEW ORLEANS, Dec. 9, 2024 /PRNewswire/ -- Gene therapies hold promise for...
Cala® Health Closes Oversubscribed $50 Million Financing To Propel Growth
SAN MATEO, Calif., Dec. 9, 2024 /PRNewswire/ -- Cala Health, the non-invasive bioelectronic medicine leader, today announced it has completed...
Essen Health Care’s ACO REACH Program Achieves 22% Savings While Transforming Care for New York’s Most Vulnerable Populations
BRONX, N.Y., Dec. 9, 2024 /PRNewswire/ -- Essen Health Care is proud to announce the successful results of its 2023...
Vertex Presents Positive Long-Term Data On CASGEVY™ (exagamglogene autotemcel) at the American Society of Hematology (ASH) Annual Meeting and Exposition and Provides Program Update
- Data from long-term follow-up of patients in clinical trials further demonstrate durability of the transformative benefits of CASGEVY™ -...
Novel Combination of Pozelimab and Cemdisiran (Poze-Cemdi) Achieved Greater Control of Intravascular Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria Compared to Ravulizumab
Head-to-head exploratory cohort of a Phase 3 trial showed first-in-class poze-cemdi combination treatment helped patients achieve and maintain greater disease...
Nordic and Benevolence Health partner to support healthcare organizations with new CMS TEAM bundled payment model
MADISON, Wis., Dec. 5, 2024 /PRNewswire/ -- Nordic®, a global health and technology consulting company, announced today a partnership with...
Therma Bright’s Distribution Partners Achieve 100% HCPCS Code Reimbursement In Under 60 Days
Distributors' medical partner networks impressed with Venowave device, speed of Medicare/Medicaid processing and prepare roadmaps to drive salesToronto, Ontario--(Newsfile Corp....